Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skin IaM: Imaging of Induced Skin Inflammation
NCT03192280Completed
- Sponsor
- LEO Pharma
- Start
- Jun 2017
- Primary completion
- Jul 2017
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by LEO Pharma. Primary endpoint: Time-point of change from baseline and comparator in electro-magnetic spectra as measured by HSI PARC at Day 3. Started Jun 2017; status: completed.
Beyond the preview
Go deeper on NCT03192280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03192280.